US5013293A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pulsating transdermal drug delivery system
Assignee: Drug Delivery Systems Inc
•
Filing: 1989-11-13
•
Granted: 1991-05-07
•
Expires: 2009-11-13
Abstract
Abstract An electrophoretic/electro-osmotic transdermal drug delivery system for passing at least one drug, or thereapeutic compound, through the skin membrane of a patient by way of a drug reservoir or gel for delivery to the systemic blood of a patient in selected, periodic pulsations. The system can be varied to accommodate various types of therapeutic compounds having varied characteristics and purposes. The system includes a current oscillator that applies periodic electrical variations to the system in order to trigger rhythmical variations of the potential and resistance of the skin membrane so as to cause oscillatory electro-osmotic streaming of the liquid with the therapeutic compound across the skin membrane in synchronization with the oscillator to the systemic blood of the patient in response to the rhythmical variations. The oscillator causes the power source to deliver a periodic pulsating current that alternates with periods of no current in the system or that alternates with periods of a different current. The pulsating current is of greater value than the different current. The pulsating current is applied for relatively short periods relative the periods of non-current or the periods of different current. The different current can be either positive or negative current. During periods of negative current the liquid with the therapeutic compound can tend to be drawn from the skin membrane into the drug reservoir or gel.
Inventors
- 👤 Dan Sibalis
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 23:27
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/0404; A61N1/0408; A61N1/0428; A61N1/0432; A61N1/044; A61N1/0448; A61N1/18; A61N1/32; A61N1/325; A61N1/0444
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
187 words
An electrolytic transdermal patch for delivering to the bloodstream of a female patient a type drug capable of inducing ovulation in a female or of causing ovulation to cease comprising in combination: (a) means defining a reservoir for containing liquid having said type drug and positioned in use in contact with the skin of the patient, (b) an electrical source of power, (c) an electrical circuit having an electrode positioned in use in contact with the skin of the patient and electrically connecting the electrode, power source and said reservoir, (d) means in said electrical circuit for causing periodic variation of current applied to said reservoir by said source of power in a rhythm similar to a natural delivery rhythm of an ovulation-causing compound of the body of the patient for effecting periodic transdermal delivery of said type of drug inducing ovulation in accordance with said natural rhythm and for selectively causing periodic variation of current delivery of said power source in a steady state mode or at a frequency greater than said natural delivery rhythm of the patient to effect ceasing of ovulation of the patient.
Claim 2
Dependent Claim
187 words
An electrolytic transdermal patch for delivering to the bloodstream of a female patient a type drug capable of inducing ovulation in a female or of causing ovulation to cease comprising in combination: (a) means defining a reservoir for containing liquid having said type drug and positioned in use in contact with the skin of the patient, (b) an electrical source of power, (c) an electrical circuit having an electrode positioned in use in contact with the skin of the patient and electrically connecting the electrode, power source and said reservoir, (d) means in said electrical circuit for causing periodic variation of current applied to said reservoir by said source of power in a rhythm similar to a natural delivery rhythm of an ovulation-causing compound of the body of the patient for effecting periodic transdermal delivery of said type of drug inducing ovulation in accordance with said natural rhythm and for selectively causing periodic variation of current delivery of said power source in a steady state mode or at a frequency greater than said natural delivery rhythm of the patient to effect ceasing of ovulation of the patient.
Claim 3
Dependent Claim
23 words
An electrolytic transdermal patch according to claim 1, in which said means in said electrical circuit for causing periodic variation comprises an oscillator.
Claim 4
Dependent Claim
193 words
An electrolytic transdermal patch for delivering to the bloodstream of a male patient a type drug capable of inducing production of testosterone in a male or of causing production of testosterone to cease comprising in combination: (a) means defining a reservoir for containing liquid having said type drug and positioned in use in contact with the skin of the patient, (b) an electrical source of power, (c) an electrical circuit having an electrode positioned in use in contact with the skin of the patient and electrically connecting the electrode, power source and said reservoir, (d) means in said electrical circuit for causing periodic variation of current applied to said reservoir by said source of power in a rhythm similar to a natural delivery rhythm of testosterone by the body of the patient for effecting periodic transdermal delivery of said type of drug inducing production of testosterone in accordance with said natural rhythm and for selectively causing periodic variation of current delivery of said power source in a steady state mode or at a frequency greater than said natural delivery rhythm of the patient to effect ceasing of production of testosterone by the patient.
Claim 5
Dependent Claim
193 words
An electrolytic transdermal patch for delivering to the bloodstream of a male patient a type drug capable of inducing production of testosterone in a male or of causing production of testosterone to cease comprising in combination: (a) means defining a reservoir for containing liquid having said type drug and positioned in use in contact with the skin of the patient, (b) an electrical source of power, (c) an electrical circuit having an electrode positioned in use in contact with the skin of the patient and electrically connecting the electrode, power source and said reservoir, (d) means in said electrical circuit for causing periodic variation of current applied to said reservoir by said source of power in a rhythm similar to a natural delivery rhythm of testosterone by the body of the patient for effecting periodic transdermal delivery of said type of drug inducing production of testosterone in accordance with said natural rhythm and for selectively causing periodic variation of current delivery of said power source in a steady state mode or at a frequency greater than said natural delivery rhythm of the patient to effect ceasing of production of testosterone by the patient.
Claim 6
Dependent Claim
23 words
An electrolytic transdermal patch according to claim 3, in which said means in said electrical circuit for causing periodic variation comprises an oscillator.
References Cited (Backward Citations)
EP0060452A1
Cited
US4820263A
Cited
US4540564A
Cited
US4764164A
Cited
EP0145493A2
Cited
US4704282A
Cited
US4689039A
Cited
US4698062A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-05-06 | 1994-11-05 | 1995-05-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-05-06 | 1998-11-05 | 1999-05-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-05-06 | 2002-11-05 | 2003-05-07 | $7700.00 | Window Closed / Lapsed |